SCHEMBL10669551

SCHEMBL10669551

Cn1c(=O)c2c(ncn2CCO[C]=O)n(C)c1=O

nearest known ligand 0.66

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 10/20 0.66
▸ MAPT P10636 1/20 0.63
▸ LMNA P02545 1/20 0.63
▸ RXFP1 Q9HBX9 3/20 0.63
▸ ADORA1 P30542 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17744966 0.84 ADORA1 (0.75) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL16120984 0.83 ADORA2B (0.81) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL18175139 0.83 ADORA2B (0.71) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL17748272 0.82 ADORA1 (0.76) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL10669558 0.81 ADORA2B (0.66) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL16120979 0.81 ADORA2B (0.85) ADORA2BMAPTLMNARXFP1ADORA1
SCHEMBL28025751 0.80 ADORA2B (1.00) ADORA2BMAPTLMNARXFP1SMN1; SMN2
SCHEMBL16121000 0.79 ADORA2B (0.85) ADORA2BMAPTLMNARXFP1ALDH1A1
SCHEMBL16120982 0.79 ADORA2B (0.85) ADORA2BMAPTLMNARXFP1ALDH1A1
SCHEMBL16120989 0.79 ADORA2B (0.85) ADORA2BMAPTLMNARXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4735959-A HYPOGLYCEMIC AGENTS DR. KARL THOMAE GMBH (DE) 1988-04-05 — — US disclosed
EP-0058779-B1 CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES Dr. Karl Thomae GmbH (DE) 1984-09-19 — — EP disclosed
EP-0058779-A2 Carboxamides, their preparation and their use as medicines Dr. Karl Thomae GmbH (DE) 1982-09-01 — — EP disclosed
Send feedback